Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1148, 2007-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Increased VTE risk of third-generation OCs not supported
Inpharma, Vol. 1, Iss. 1252, 2000-01 ,pp. :
Access to resources
Recommend
Oral but not transdermal estrogens increase VTE risk
Inpharma, Vol. 1, Iss. 1400, 2003-01 ,pp. :
Newer CHCs linked to higher risk of VTE, says FDA report
Reactions Weekly, Vol. 1, Iss. 1376, 2011-01 ,pp. :
Third-generation OCs: increased VTE risk supported by new analyses
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :
Linezolid linked to increased risk of death
Inpharma, Vol. 1, Iss. 1580, 2007-01 ,pp. :